Videos
- August 28, 2013
- August 28, 2013
-
November 29, 2012
C-Path Cosponsors Workshop on Combination Drug Development for Alzheimer’s Disease
Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches were established to identify necessary pathways and tools that enabled more efficient trials. The primary goal of this meeting held in Baltimore, MD November 29th 2012 was to explore how similar partnerships could foster more robust collaboration in Alzheimer’s disease... - November 9, 2011
-
November 8, 2011
Brian Harvey, VP, U.S. Regulatory Policy at Sanofi, speaks on panel at Partnering for Cures Nov. 8, 2011
Highlights benefits of public-private partnerships like C-Path’s Coalition Against Major Diseases (CAMD): Stresses importance of standardization when pooling clinical trial data: